Table 1.
Demographics and perioperative variables of pancreatectomy subjects
| Variable | Subjects (N = 227) |
|---|---|
| Age, years (range) | 62 (22–88) |
| BMI, kg/m2 (range) | 27 (16–56) |
| Gender, N (%) | |
| Male | 107 (47) |
| Female | 120 (53) |
| Resection Type, N (%) | |
| Pancreaticoduodenectomy | 159 (70) |
| Distal pancreatectomy | 63 (28) |
| Enucleation | 5 (2) |
| Pathology, N (%) | |
| Benign | |
| IPMN | 35 (15) |
| Serous cystadenoma | 10 (4) |
| Mucinous cystadenoma | 7 (3) |
| GIST | 2 (1) |
| Others | 18 (8) |
| Malignant | |
| PDAC | 100 (44) |
| Ampullary adenocarcinoma | 28 (12) |
| Neuroendocrine carcinoma | 13 (6) |
| Cholangiocarcinoma | 9 (4) |
| Duodenal adenocarcinoma | 4 (2) |
| Metastasis | 1 (0.4) |
| Tumor location, N (%) | |
| Head | 150 (66) |
| Body | 35 (15) |
| Tail | 27 (12) |
| Unknown | 15 (7) |
| Tumor size, cm (range) | 3.0 (0.2–17.0) |
| Pancreatitis on pathology, N (%) | |
| Yes | 57 (25) |
| No | 153 (67) |
| Unknown | 17 (7) |
| Chemotherapy, N (%) | |
| Neoadjuvant | 18 (8) |
| Adjuvant | 109 (48) |
| Radiation, N (%) | |
| Neoadjuvant | 17 (8) |
| Adjuvant | 80 (35) |
BMI, body mass index; GIST, gastrointestinal stromal tumor; IPMN, intraductal papillary mucinous neoplasm; PDAC, pancreatic ductal adenocarcinoma.